{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:47:04Z","timestamp":1788562024810,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["SAF-94814"],"award-info":[{"award-number":["SAF-94814"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High levels of opioid-related mortality, as well as morbidity, contribute to the excessive opioid-related disease burden in North America, induced by high availability of opioids. While correlations between opioid dispensing levels and mortality outcomes are well-established, fewer evidence exists on correlations with morbidity (e.g., hospitalizations).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined possible overtime correlations between medical opioid dispensing and opioid-related hospitalizations in Canada, by province, 2007\u20132016. For dispensing, we examined annual volumes of medical opioid dispensing derived from a representative, stratified sample of retail pharmacies across Canada. Raw dispensing information for \u2018strong opioids\u2019 was converted into Defined Daily Doses per 1000 population per day (DDD\/1000\/day). Opioid-related hospitalization rates referred to opioid poisoning-related admissions by province, for fiscal years 2007\u201308 to 2016\u201317, drawn from the national Hospital Morbidity Database. We assessed possible correlations between opioid dispensing and hospitalizations by province using the Pearson product moment correlation; correlation values (r) and confidence intervals were reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Significant correlations for overtime correlations between population-levels of opioid dispensing and opioid-related hospitalizations were observed for three provinces: Quebec (\n                      <jats:italic>r<\/jats:italic>\n                      \u00a0=\u20090.87, CI: 0.49\u20130.97;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.002); New Brunswick (\n                      <jats:italic>r<\/jats:italic>\n                      \u00a0=\u20090.85;CI: 0.43\u20130.97;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.004) and Nova Scotia (\n                      <jats:italic>r<\/jats:italic>\n                      \u00a0=\u20090.78; CI:0.25\u20130.95;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.012), with an additional province, Saskatchewan, (\n                      <jats:italic>r<\/jats:italic>\n                      \u00a0=\u20090.073; CI:-0.07\u20130.91;\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.073) featuring borderline significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The correlations observed further add to evidence on opioid dispensing levels as a systemic driver of population-level harms. Notably, correlations were not identified principally in provinces with reported high contribution levels (&gt;\u200950%) of illicit opioids to mortality, which are not captured by dispensing data and so may have distorted or concealed potential correlation effects due to contamination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-020-05530-w","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T06:04:10Z","timestamp":1595397850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007\u20132016"],"prefix":"10.1186","volume":"20","author":[{"given":"Wayne","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kurdyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2186-4030","authenticated-orcid":false,"given":"Benedikt","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"5530_CR1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","volume":"36","author":"A Kolodny","year":"2015","unstructured":"Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559\u201374.","journal-title":"Annu Rev Public Health"},{"key":"5530_CR2","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/add.12598","volume":"109","author":"T Gomes","year":"2014","unstructured":"Gomes T, Mamdani MM, Dhalla IA, Cornish S, Paterson JM, Juurlink DN. The burden of premature opioid-related mortality. Addiction. 2014;109:1482\u20138.","journal-title":"Addiction"},{"issue":"17\u201318","key":"5530_CR3","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1503\/cmaj.160356","volume":"188","author":"B Fischer","year":"2016","unstructured":"Fischer B, Rehm J, Tyndall M. Effective Canadian policy to reduce harms from prescription opioids: learning from past failures. CMAJ. 2016;188(17\u201318):1240\u20134.","journal-title":"CMAJ"},{"issue":"6","key":"5530_CR4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.24095\/hpcdp.38.6.02","volume":"38","author":"L Belzak","year":"2018","unstructured":"Belzak L, Halverson J. Evidence synthesis-The opioid crisis in Canada: a national perspective. Health Promot Chron Dis Prev Can: Res Policy Pract. 2018;38(6):224.","journal-title":"Health Promot Chron Dis Prev Can: Res Policy Pract"},{"issue":"15","key":"5530_CR5","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016. JAMA. 2016;315(15):1624\u201345.","journal-title":"JAMA"},{"key":"5530_CR6","volume-title":"Drug and opioid-involved overdose deaths - United States, 2013\u20132017","author":"L Scholl","year":"2019","unstructured":"Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths - United States, 2013\u20132017. Atlanta, USA: Centre for Disease Control and Prevention; 2019."},{"key":"5530_CR7","volume-title":"National Report: apparent opioid-related deaths in Canada","author":"Government of Canada","year":"2019","unstructured":"Government of Canada. National Report: apparent opioid-related deaths in Canada. Ottawa, ON: Government of Canada; 2019."},{"key":"5530_CR8","doi-asserted-by":"crossref","first-page":"k3207","DOI":"10.1136\/bmj.k3207","volume":"362","author":"T Gomes","year":"2018","unstructured":"Gomes T, Khuu W, Martins D, Tadrous M, Mamdani MM, Paterson JM, et al. Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada. BMJ. 2018;362:k3207.","journal-title":"BMJ"},{"key":"5530_CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","volume":"134","author":"P Armenian","year":"2018","unstructured":"Armenian P, Vo KT, Barr-Walker J, Lynch KL. Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology. 2018;134:121\u201332.","journal-title":"Neuropharmacology"},{"issue":"2","key":"5530_CR10","doi-asserted-by":"crossref","first-page":"e54496","DOI":"10.1371\/journal.pone.0054496","volume":"8","author":"GJ Unick","year":"2013","unstructured":"Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin-and opioid-related overdoses, 1993-2009. PLoS One. 2013;8(2):e54496.","journal-title":"PLoS One"},{"issue":"5","key":"5530_CR11","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","volume":"35","author":"MV Ronan","year":"2016","unstructured":"Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002\u201312. Health Aff. 2016;35(5):832\u20137.","journal-title":"Health Aff"},{"issue":"9","key":"5530_CR12","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/add.13795","volume":"112","author":"DJ Hsu","year":"2017","unstructured":"Hsu DJ, McCarthy EP, Stevens JP, Mukamal KJ. Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001\u201312. Addiction. 2017;112(9):1558\u201364.","journal-title":"Addiction."},{"issue":"12","key":"5530_CR13","doi-asserted-by":"crossref","first-page":"e0167479","DOI":"10.1371\/journal.pone.0167479","volume":"11","author":"L Spooner","year":"2016","unstructured":"Spooner L, Fernandes K, Martins D, Juurlink D, Mamdani M, Paterson JM, et al. High-dose opioid prescribing and opioid-related hospitalization: a population-based study. PLoS One. 2016;11(12):e0167479.","journal-title":"PLoS One"},{"issue":"1","key":"5530_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/dar.12089","volume":"33","author":"B Fischer","year":"2014","unstructured":"Fischer B, Jones W, Urbanoski K, Skinner R, Rehm J. Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011. Drug Alcohol Rev. 2014;33(1):19\u201326.","journal-title":"Drug Alcohol Rev"},{"issue":"26","key":"5530_CR15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","volume":"66","author":"GP Guy Jr","year":"2017","unstructured":"Guy GP Jr, Zhand K, Bohm MK, Losby J, Lewis B, Young R, et al. Vital signs: changes in opioid prescribing in the United States, 2006-2015. Morb Mortal Wkly Rep. 2017;66(26):697.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"7","key":"5530_CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AJP.0000000000000011","volume":"30","author":"AS Bohnert","year":"2014","unstructured":"Bohnert AS, Ilgen MA, Trafton JA, Kerns RD, Eisenberg A, Ganoczy D, et al. Trends and regional variation in opioid overdose mortality among veterans health administration patients, fiscal year 2001 to 2009. Clin J Pain. 2014;30(7):605\u201312.","journal-title":"Clin J Pain"},{"issue":"1","key":"5530_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v27n01_01","volume":"27","author":"AM Wisniewski","year":"2008","unstructured":"Wisniewski AM, Purdy CH, Blondell RD. The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. J Addict Dis. 2008;27(1):1\u201311.","journal-title":"J Addict Dis"},{"key":"5530_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drugalcdep.2013.01.006","volume":"132","author":"F Modarai","year":"2013","unstructured":"Modarai F, Mack K, Hicks P, Benoit S, Park S, Jones C, et al. Relationship of opioid prescription sales and overdoses, North Carolina. Drug Alcohol Depend. 2013;132:81\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"5530_CR19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.drugalcdep.2013.05.017","volume":"133","author":"EK Sauber-Schatz","year":"2013","unstructured":"Sauber-Schatz EK, Mack KA, Kiekman ST, Paulozzi L. Associations between pain clinic density and distributions of opioid pain relievers, drug-related deaths, hospitalizations, emergency department visits, and neonatal abstinence syndrome in Florida. Drug Alcohol Depend. 2013;133(1):161\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"5530_CR20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/1753-6405.12568","volume":"41","author":"J Berecki-Gisolf","year":"2017","unstructured":"Berecki-Gisolf J, Hassani-Mahmooei B, Clapperton A, McClure R. Prescription opioid dispensing and prescription opioid poisoning: population data from Victoria, Australia 2006 to 2013. Aust N Z J Public Health. 2017;41(1):85\u201391.","journal-title":"Aust N Z J Public Health"},{"issue":"5","key":"5530_CR21","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/bcp.12446","volume":"78","author":"B Blanch","year":"2014","unstructured":"Blanch B, Pearson SA, Haber PS. An overview of the patterns of prescription opioid use, costs and related harms in a ustralia. Br J Clin Pharmacol. 2014;78(5):1159\u201366.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"5530_CR22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.36076\/ppj.2018.3.219","volume":"21","author":"B Fischer","year":"2018","unstructured":"Fischer B, Jones W, Vojtila L, Kurdyak P. Patterns, changes, and trends in prescription opioid dispensing in Canada, 2005-2016. Pain Physician. 2018;21(3):219\u201328.","journal-title":"Pain Physician"},{"key":"5530_CR23","volume-title":"Pan-Canadian Trends in the Prescribing of Opioids and Benzodiazepines, 2012 to 2017","author":"CIHI","year":"2018","unstructured":"CIHI. Pan-Canadian Trends in the Prescribing of Opioids and Benzodiazepines, 2012 to 2017. Ottawa, ON: Canadian Institute for Health Information (CIHI); 2018."},{"key":"5530_CR24","unstructured":"IQVIA. Canadian Pharmaceutical Trends: IQVIA; 2019. Available from: https:\/\/www.iqvia.com\/locations\/canada\/canadian-pharmaceutical-trends."},{"issue":"7\u20138","key":"5530_CR25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.14745\/ccdr.v44i78a01","volume":"44","author":"D Schanzer","year":"2018","unstructured":"Schanzer D, Pogany L, Aho J, Tomas K, Gale-Rowe M, Kwong J, et al. Can we eliminate hepatitis C?: impact of availability of direct-acting antivirals for hepatitis C on Canadian hospitalization rates, 2012\u20132016. Can Commun Dis Rep. 2018;44(7\u20138):150.","journal-title":"Can Commun Dis Rep"},{"issue":"7","key":"5530_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/0269216311398300","volume":"25","author":"K Svendsen","year":"2011","unstructured":"Svendsen K, Borchgrevink P, Fredheim O, Hamunen K, Mellbye A, Dale O. Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses. Palliat Med. 2011;25(7):725\u201332.","journal-title":"Palliat Med"},{"issue":"1","key":"5530_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/009286150403800104","volume":"38","author":"IS Sketris","year":"2004","unstructured":"Sketris IS, Metge CJ, Ross JL, MacCara ME, Comeau DG, Kephart GC, et al. The use of the World Health Organisation anatomical therapeutic chemical\/defined daily dose methodology in Canada. Drug Inf J. 2004;38(1):15\u201327.","journal-title":"Drug Inf J"},{"issue":"5","key":"5530_CR28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/pds.4168","volume":"26","author":"S Nielsen","year":"2017","unstructured":"Nielsen S, Gisev N, Bruno R, Hall W, Cohen M, Larance B, et al. Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment. Pharmacoepidemiol Drug Saf. 2017;26(5):587\u201391.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"5530_CR29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jcpt.12110","volume":"39","author":"R Raffa","year":"2014","unstructured":"Raffa R, Pergolizzi J Jr. A modern analgesics pain \u2018pyramid\u2019. J Clin Pharm Ther. 2014;39(1):4\u20136.","journal-title":"J Clin Pharm Ther"},{"key":"5530_CR30","unstructured":"CIHI. Hospitalizations and Emergency Department Visits Due to Opioid Poisoning in Canada. Ottawa, ON: Canadian Institute for Health Information (CIHI); 2016. Available from: https:\/\/secure.cihi.ca\/free_products\/Opioid%20Poisoning%20Report%20%20EN.pdf."},{"key":"5530_CR31","volume-title":"Hospital Morbidity Database","author":"CIHI","year":"2019","unstructured":"CIHI. Hospital Morbidity Database. Ottawa, ON: Canadian Institutes for Health Information (CIHI); 2019. Available from: https:\/\/www.cihi.ca\/en\/hospital-morbidity-database."},{"key":"5530_CR32","unstructured":"Core R. Team. R: a language and environment for statistical computing Vienna, Austria: R Foundation for statistical. Computing. 2018; Available from: https:\/\/www.R-project.org\/."},{"issue":"10","key":"5530_CR33","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","volume":"54","author":"C Florence","year":"2016","unstructured":"Florence C, Luo F, Xu L, Zhou C. The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013. Med Care. 2016;54(10):901.","journal-title":"Med Care"},{"key":"5530_CR34","doi-asserted-by":"crossref","unstructured":"Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. The burden of opioid-related mortality in the United States. JAMA Netw Open. 2018;1(2):e180217-e.","DOI":"10.1001\/jamanetworkopen.2018.0217"},{"key":"5530_CR35","doi-asserted-by":"crossref","unstructured":"Belzak L, Halverson J. The opioid crisis in Canada: a national perspective. Health Promot Chron Dis Prev Can: Res Policy Pract. 2018;38(6):224\u201333.","DOI":"10.24095\/hpcdp.38.6.02"},{"key":"5530_CR36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugpo.2017.06.003","volume":"46","author":"G Unick","year":"2017","unstructured":"Unick G, Ciccarone D. US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations. Int J Drug Policy. 2017;46:112\u20139.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"5530_CR37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ejp.1291","volume":"23","author":"C Chenaf","year":"2019","unstructured":"Chenaf C, Kabor\u00e9 JL, Delorme J, Pereira B, Mulliez A, Zenut M, et al. Prescription opioid analgesic use in France: trends and impact on morbidity\u2013mortality. Eur J Pain. 2019;23(1):124\u201334.","journal-title":"Eur J Pain"},{"issue":"18","key":"5530_CR38","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.1503\/cmaj.170363","volume":"189","author":"JW Busse","year":"2017","unstructured":"Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ. 2017;189(18):E659\u2013E66.","journal-title":"CMAJ"},{"issue":"4","key":"5530_CR39","doi-asserted-by":"crossref","first-page":"E256","DOI":"10.9778\/cmajo.20140027","volume":"2","author":"T Gomes","year":"2014","unstructured":"Gomes T, Juurlink D, Yao Z, Camacho X, Paterson JM, Singh S, et al. Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis. CMAJ Open. 2014;2(4):E256.","journal-title":"CMAJ Open"},{"issue":"10","key":"5530_CR40","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","volume":"35","author":"D Dowell","year":"2016","unstructured":"Dowell D, Zhang K, Noonan RK, Hockenberry JM. Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates. Health Aff. 2016;35(10):1876\u201383.","journal-title":"Health Aff"},{"key":"5530_CR41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ypmed.2017.11.001","volume":"107","author":"B Fischer","year":"2018","unstructured":"Fischer B, Vojtila L, Rehm J. The \u2018fentanyl epidemic\u2019in Canada\u2013some cautionary observations focusing on opioid-related mortality. Prev Med. 2018;107:109\u201313.","journal-title":"Prev Med"},{"key":"5530_CR42","first-page":"E605","volume":"18","author":"Y Murphy","year":"2015","unstructured":"Murphy Y, Goldner E, Fischer B. Prescription opioid use, harms and interventions in Canada: a review update of new developments and findings since 2010. Pain Physician. 2015;18:E605\u2013E14.","journal-title":"Pain Physician"},{"key":"5530_CR43","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.drugalcdep.2017.12.032","volume":"185","author":"N Baldwin","year":"2018","unstructured":"Baldwin N, Gray R, Goel A, Wood E, Buxton JA, Rieb LM. Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: an observational analysis. Drug Alcohol Depend. 2018;185:322\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"5530_CR44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","volume":"46","author":"N Fairbairn","year":"2017","unstructured":"Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172\u20139.","journal-title":"Int J Drug Policy"},{"key":"5530_CR45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.drugalcdep.2018.06.028","volume":"191","author":"T Gomes","year":"2018","unstructured":"Gomes T, Khuu W, Craiovan D, Martins D, Hunt J, Lee K, et al. Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: a multi-jurisdictional cross-sectional study. Drug Alcohol Depend. 2018;191:86\u201390.","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"5530_CR46","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/add.12551","volume":"109","author":"L Degenhardt","year":"2014","unstructured":"Degenhardt L, Charlson F, Mathers B, Hall WD, Flaxman AD, Johns N, et al. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction. 2014;109(8):1320\u201333.","journal-title":"Addiction"},{"issue":"11","key":"5530_CR47","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jama.2017.9308","volume":"318","author":"D Dowell","year":"2017","unstructured":"Dowell D, Arias E, Kochanek K, Anderson R, Guy GP, Losby JL, et al. Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000-2015. JAMA. 2017;318(11):1065\u20137.","journal-title":"JAMA"},{"issue":"8","key":"5530_CR48","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.2105\/AJPH.2014.301966","volume":"104","author":"NB King","year":"2014","unstructured":"King NB, Fraser V, Boikos C, Richardson R, Harper S. Determinants of increased opioid-related mortality in the United States and Canada, 1990\u20132013: a systematic review. Am J Public Health. 2014;104(8):e32\u201342.","journal-title":"Am J Public Health"},{"key":"5530_CR49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.drugalcdep.2014.03.002","volume":"138","author":"ER Wright","year":"2014","unstructured":"Wright ER, Kooreman HE, Greene MS, Chambers RA, Banerjee A, Wilson J. The iatrogenic epidemic of prescription drug abuse: county-level determinants of opioid availability and abuse. Drug Alcohol Depend. 2014;138:209\u201315.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"5530_CR50","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/pds.3404","volume":"22","author":"B Fischer","year":"2013","unstructured":"Fischer B, Jones W, Rehm J. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005\u20132009. Pharmacoepidemiol Drug Saf. 2013;22(4):438\u201342.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"5530_CR51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/add.12224","volume":"109","author":"B Fischer","year":"2014","unstructured":"Fischer B, Keates A, B\u00fchringer G, Reimer J, Rehm J. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? Addiction. 2014;109(2):177\u201381.","journal-title":"Addiction"},{"key":"5530_CR52","doi-asserted-by":"crossref","unstructured":"Els C, Jackson TD, Hagtvedt R, Kunyk D, Sonnenberg B, Lappi VG, et al. High-dose opioids for chronic non-cancer pain: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;10.","DOI":"10.1002\/14651858.CD012299"},{"issue":"1","key":"5530_CR53","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/2046-4053-2-66","volume":"2","author":"JW Busse","year":"2013","unstructured":"Busse JW, Schandelmaier S, Kamaleldin M, Hsu S, Riva JJ, Vandvik PO, et al. Opioids for chronic non-cancer pain: a protocol for a systematic review of randomized controlled trials. Syst Rev. 2013;2(1):66.","journal-title":"Syst Rev"},{"issue":"2","key":"5530_CR54","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S2468-2667(18)30232-9","volume":"4","author":"B Fischer","year":"2018","unstructured":"Fischer B, Pang M, Tyndall M. The opioid death crisis in Canada: crucial lessons for public health. Lancet Public Health. 2018;4(2):e81\u2013e2.","journal-title":"Lancet Public Health"},{"issue":"10028","key":"5530_CR55","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","volume":"387","author":"S Berterame","year":"2016","unstructured":"Berterame S, Erthal J, Thomas J, Fellner S, Vosse B, Clare P, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387(10028):1644\u201356.","journal-title":"Lancet"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05530-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-020-05530-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05530-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T19:44:23Z","timestamp":1626896663000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-020-05530-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5530"],"URL":"https:\/\/doi.org\/10.1186\/s12913-020-05530-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.18920\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18920\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.18920\/v2","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No administrative permissions were required to access and use the data and records described in this manuscript. The prescription opioid dispensing data were generated based on retail dispensing information commercially obtained from IQVIA. The provider had no involvement in any stages of the study design, results, interpretation or decision to publish.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"677"}}